Updated
Reviewed Apr. 11, 2023

Appendix B: Acronyms

Study and Trial Names

Acronym Name
ACTG AIDS Clinical Trials Group
AMP Adolescent Master Protocol 
ANRS National Agency for AIDS Research (France)
ARROW Anti-retroviral research for Watoto
ATHENA AIDS Therapy Evaluation in the Netherlands
ATLAS Antiretroviral Therapy as Long-Acting Suppression
ATN Adolescent Trials Network
BAN Breastfeeding, Antiretrovirals, and Nutrition
CHAPAS Children with HIV in Africa—Pharmacokinetics and Acceptability of Simple second-line antiretroviral regimens
CHER Children with HIV Early Antiretroviral Therapy
CRAFFT Car, Relax, Alone, Forget, Friends, and Trouble
DIONE A Study to Evaluate Antiviral Activity of Darunavir + Ritonavir in HIV-1 Infected Adolescents
DolPHIN-2 Dolutegravir in Pregnant HIV Mothers and Their Neonates
ENCORE Evaluation of Novel Concepts in Optimization of antiRetroviral Efficacy
EPIICAL Early-treated Perinatally HIV-infected Individuals: Improving Children’s Actual Life with Novel Immunotherapeutic Strategies
EPPICC European Pregnancy and Paediatric Infections Cohort Collaboration
FLAIR First Long-Acting Injectable Regimen
HPPM HIV Paediatric Prognostic Markers
HPTN HIV Prevention Trials Network
IeDEA International Epidemiology Databases to Evaluate AIDS
IMPAACT International Maternal Pediatric Adolescent AIDS Clinical Trials
MOCHA More Options for Children and Adolescents
NEVEREST Nevirapine Resistance Study
ODYSSEY Once-daily DTG based ART in Young people vS Standard thErapY
PACTG Pediatric AIDS Clinical Trials Group
PENPACT Trial run in collaboration between PENTA and PACTG/IMPAACT
PENTA Paediatric European Network for Treatment of AIDS
PEPFAR President’s Emergency Plan for AIDS Relief
PHACS Pediatric HIV/AIDS Cohort Study
PIANO Paediatric study of Intelence As an NNRTI Option
PREDICT Early Versus Deferred Antiretroviral Therapy for Children Older Than 1 Year Infected with HIV
PROMISE Promoting Maternal and Infant Survival Everywhere Study
PROMOTE PEPFAR PROMise Ongoing Treatment Evaluation
SBIRT Screening, Brief Intervention, and Referral to Treatment
SMILE Strategy for Maintenance of HIV Suppression With Once Daily Integrate Inhibitor+Darunavir/Ritonavir in Children
START Strategic Timing of AntiRetroviral Treatment

Appendix B: Acronyms

Study and Trial Names

Acronym Name
ACTG AIDS Clinical Trials Group
AMP Adolescent Master Protocol 
ANRS National Agency for AIDS Research (France)
ARROW Anti-retroviral research for Watoto
ATHENA AIDS Therapy Evaluation in the Netherlands
ATLAS Antiretroviral Therapy as Long-Acting Suppression
ATN Adolescent Trials Network
BAN Breastfeeding, Antiretrovirals, and Nutrition
CHAPAS Children with HIV in Africa—Pharmacokinetics and Acceptability of Simple second-line antiretroviral regimens
CHER Children with HIV Early Antiretroviral Therapy
CRAFFT Car, Relax, Alone, Forget, Friends, and Trouble
DIONE A Study to Evaluate Antiviral Activity of Darunavir + Ritonavir in HIV-1 Infected Adolescents
DolPHIN-2 Dolutegravir in Pregnant HIV Mothers and Their Neonates
ENCORE Evaluation of Novel Concepts in Optimization of antiRetroviral Efficacy
EPIICAL Early-treated Perinatally HIV-infected Individuals: Improving Children’s Actual Life with Novel Immunotherapeutic Strategies
EPPICC European Pregnancy and Paediatric Infections Cohort Collaboration
FLAIR First Long-Acting Injectable Regimen
HPPM HIV Paediatric Prognostic Markers
HPTN HIV Prevention Trials Network
IeDEA International Epidemiology Databases to Evaluate AIDS
IMPAACT International Maternal Pediatric Adolescent AIDS Clinical Trials
MOCHA More Options for Children and Adolescents
NEVEREST Nevirapine Resistance Study
ODYSSEY Once-daily DTG based ART in Young people vS Standard thErapY
PACTG Pediatric AIDS Clinical Trials Group
PENPACT Trial run in collaboration between PENTA and PACTG/IMPAACT
PENTA Paediatric European Network for Treatment of AIDS
PEPFAR President’s Emergency Plan for AIDS Relief
PHACS Pediatric HIV/AIDS Cohort Study
PIANO Paediatric study of Intelence As an NNRTI Option
PREDICT Early Versus Deferred Antiretroviral Therapy for Children Older Than 1 Year Infected with HIV
PROMISE Promoting Maternal and Infant Survival Everywhere Study
PROMOTE PEPFAR PROMise Ongoing Treatment Evaluation
SBIRT Screening, Brief Intervention, and Referral to Treatment
SMILE Strategy for Maintenance of HIV Suppression With Once Daily Integrate Inhibitor+Darunavir/Ritonavir in Children
START Strategic Timing of AntiRetroviral Treatment

Download Guidelines